Skip to main content

Research Repository

Advanced Search

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose

Reynolds, Catherine J.; Pade, Corinna; Gibbons, Joseph M.; Butler, David K.; Otter, Ashley D.; Menacho, Katia; Fontana, Marianna; Smit, Angelique; Sackville-West, Jane E.; Cutino-Moguel, Teresa; Maini, Mala K.; Chain, Benjamin; Noursadeghi, Mahdad; Brooks, Tim; Semper, Amanda; Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.; Valdes, Ana M.; McKnight, �ine; Altmann, Daniel M.; Boyton, Rosemary; UK COVIDsortium Immune Correlates Network; UK COVIDsortium Investigators

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose Thumbnail


Authors

Catherine J. Reynolds

Corinna Pade

Joseph M. Gibbons

David K. Butler

Ashley D. Otter

Katia Menacho

Marianna Fontana

Angelique Smit

Jane E. Sackville-West

Teresa Cutino-Moguel

Mala K. Maini

Benjamin Chain

Mahdad Noursadeghi

Tim Brooks

Amanda Semper

Charlotte Manisty

Thomas A. Treibel

James C. Moon

�ine McKnight

Daniel M. Altmann

Rosemary Boyton

UK COVIDsortium Immune Correlates Network

UK COVIDsortium Investigators



Abstract

SARS-CoV-2 vaccine rollout has coincided with the spread of variants of concern. We investigated if single dose vaccination, with or without prior infection, confers cross protective immunity to variants. We analyzed T and B cell responses after first dose vaccination with the Pfizer/BioNTech mRNA vaccine BNT162b2 in healthcare workers (HCW) followed longitudinally, with or without prior Wuhan-Hu-1 SARS-CoV-2 infection. After one dose, individuals with prior infection showed enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351. By comparison, HCW receiving one vaccine dose without prior infection showed reduced immunity against variants. B.1.1.7 and B.1.351 spike mutations resulted in increased, abrogated or unchanged T cell responses depending on human leukocyte antigen (HLA) polymorphisms. Single dose vaccination with BNT162b2 in the context of prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants.

Citation

Reynolds, C. J., Pade, C., Gibbons, J. M., Butler, D. K., Otter, A. D., Menacho, K., …UK COVIDsortium Investigators. (2021). Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose. Science, 372(6549), 1418-1423. https://doi.org/10.1126/science.abh1282

Journal Article Type Article
Acceptance Date Apr 26, 2021
Online Publication Date Apr 30, 2021
Publication Date Jun 25, 2021
Deposit Date May 9, 2021
Publicly Available Date Jun 8, 2021
Journal Science
Print ISSN 0036-8075
Electronic ISSN 1095-9203
Publisher American Association for the Advancement of Science
Peer Reviewed Peer Reviewed
Volume 372
Issue 6549
Pages 1418-1423
DOI https://doi.org/10.1126/science.abh1282
Public URL https://nottingham-repository.worktribe.com/output/5521853
Publisher URL https://science.sciencemag.org/content/early/2021/04/29/science.abh1282/tab-article-info

Files




You might also like



Downloadable Citations